This Website use Cookies OK

Read more travel News

$5 million gifted to study cannabis for common childhood disorder


The study will be based at the University of California San Diego School of Medicine's Center for Medicinal Cannabis Research (CMCR) and involve a multidisciplinary team of physicians and scientists employing basic research, computational technologies, stem cells, imaging and clinical assessments to better understand how CBD interacts with or alters neural activity. The study also will measure if CBD effectively and safely alleviates some of the more problematic symptoms of ASD, such as aggressive behaviors, repetitive or self-injurious behaviors, hyperactivity and social and communicative deficits. CBD is a chemical ingredient in marijuana that is non-psychoactive. In other words, it doesn't cause the "euphoric" sensation.